News | March 16, 2010

Radioembolization Study Identifies Patient Profile for Treatment

March 16, 2010 - Physicians took new steps toward understanding what patient type would benefit most from Yttrium-90 radioembolization treatment for hepatocellular carcinoma (HCC).

Radioembolization treatment, commercially known as TheraSphere, is a liver cancer therapy that consists of millions of small glass beads (20 to 30 micrometers in diameter)containing radioactive yttrium-90. The product is injected by physicians into the main artery of the patient's liver through a catheter, which allows the treatment to be delivered directly to the tumor via blood vessels.  

Doctors presented their results the 2010 Society of Interventional Radiology (SIR) 35th Annual Scientific Meeting. In one of the presentations, Riad Salem, M.D., interventional radiologist and professor of radiology, medicine and surgery at Northwestern University, Chicago, Ill., and Robert Lewandowski, M.D., a co-author and an interventional radiologist at Northwestern Memorial Hospital, explained how they assessed clinical outcomes utilizing TheraSphere in 291 patients suffering from HCC. presented a comprehensive analysis of the findings.

Dr. Salem said they were able to determine what particular patient type would benefit from this treatment, and that the study could support future studies of similar scope.
Steve Hong, M.D., a radiologist at William Beaumont Hospital, Royal Oak, Michigan, presented a study addressing the deterioration in liver function following radioembolization treatment for HCC, for which the principal investigator was Michael Savin, M.D., an interventional radiology researcher also from William Beaumont Hospital. The study concluded that while liver deterioration is a known complication of radioembolization, most liver deterioration appeared to occur due to underlying cirrhosis or further progression of the patient's liver cancer.

For more information:

Related Content

Image courtesy of Philips

Image courtesy of Philips

Feature | Interventional Radiology | July 05, 2018 | By Jeff Zagoudis
On May 14, 2018, First Lady Melania Trump underwent an embolization procedure for what was called a benign kidney...
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. Angiogram of a kidney.

First Lady Melania Trump in hospital to undergo an interventional radiology (IR) catheter embolization procedure in her kidneys. The left image is an example of a kidney angiogram to highlight the renal blood vessels during an interventional procedure.

News | Interventional Radiology | May 15, 2018 | Dave Fornell
May 15, 2018 — U.S.
Capitol Hill Briefing Explores Role of Interventional Radiology in Healthcare
News | Interventional Radiology | May 09, 2018
The Society of Interventional Radiology (SIR), in conjunction with Rep. Mia Love (R-Utah) participated in a panel...
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
Overlay Init